The prevalence of primary aldosteronism is much higher than previously thought. Recent studies have shown that primary aldosteronism is related to a higher risk of cardiovascular events. However, the underlying mechanism is not yet clear. Here we investigate the characteristics, including inflammation, fibrosis, and adipokine expression, of adipose tissues from different deposits in patients with aldosterone-producing adenoma (APA). Inflammation and fibrosis changes were evaluated in perirenal and subcutaneous adipose tissues obtained from patients with APA (n = 16), normotension (NT; n = 10), and essential hypertension (EH; n = 5) undergoing laparoscopic surgery. We also evaluated the effect of aldosterone in isolated human perirenal adipose tissue stromal vascular fraction (SVF) cells and investigated the effect of aldosterone in mouse 3T3-L1 and brown preadipocytes. Compared with the EH group, significantly higher levels of interleukin-6 (IL-6) and tumor necrosis factor-a messenger RNA (mRNA) and protein were observed in perirenal adipose tissue of patients with APA. Expression of genes related to fibrosis and adipogenesis in perirenal adipose tissue was notably higher in patients with APA than in patients with NT and EH. Aldosterone significantly induced IL-6 and fibrosis gene mRNA expression in differentiated SVF cells. Aldosterone treatment enhanced mRNA expression of genes associated with inflammation and fibrosis and stimulated differentiation of 3T3-L1 and brown preadipocytes. In conclusion, these data indicate that high aldosterone in patients with APA may induce perirenal adipose tissue dysfunction and lead to inflammation and fibrosis, which may be involved in the high risk of cardiovascular events observed in patients with primary aldosteronism. (Endocrinology 159: 227-237, 2018) 
The prevalence of primary aldosteronism is much higher than previously thought. Recent studies have shown that primary aldosteronism is related to a higher risk of cardiovascular events. However, the underlying mechanism is not yet clear. Here we investigate the characteristics, including inflammation, fibrosis, and adipokine expression, of adipose tissues from different deposits in patients with aldosterone-producing adenoma (APA). Inflammation and fibrosis changes were evaluated in perirenal and subcutaneous adipose tissues obtained from patients with APA (n = 16), normotension (NT; n = 10), and essential hypertension (EH; n = 5) undergoing laparoscopic surgery. We also evaluated the effect of aldosterone in isolated human perirenal adipose tissue stromal vascular fraction (SVF) cells and investigated the effect of aldosterone in mouse 3T3-L1 and brown preadipocytes. Compared with the EH group, significantly higher levels of interleukin-6 (IL-6) and tumor necrosis factor-a messenger RNA (mRNA) and protein were observed in perirenal adipose tissue of patients with APA. Expression of genes related to fibrosis and adipogenesis in perirenal adipose tissue was notably higher in patients with APA than in patients with NT and EH. Aldosterone significantly induced IL-6 and fibrosis gene mRNA expression in differentiated SVF cells. Aldosterone treatment enhanced mRNA expression of genes associated with inflammation and fibrosis and stimulated differentiation of 3T3-L1 and brown preadipocytes. In conclusion, these data indicate that high aldosterone in patients with APA may induce perirenal adipose tissue dysfunction and lead to inflammation and fibrosis, which may be involved in the high risk of cardiovascular events observed in patients with primary aldosteronism. (Endocrinology 159: [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] 2018) T o date, accumulating evidence has demonstrated that the incidence of primary aldosteronism (PA) is much higher than previously believed (1) . Compared with patients with essential hypertension (EH) matched for blood pressure, sex, and age, patients with PA have an increased rate of cardiovascular events and mortality (2, 3) . And the prevalence of type 2 diabetes and metabolic syndrome are higher in PA than in matched patients with EH (4) . Adipose tissue inflammation and fibrosis play an important role in cardiovascular disease. In patients with high-risk heart disease, epicardial adipose tissue expresses significantly higher levels of interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) compared with subcutaneous adipose tissue (5) . A previous study has reported that aldosterone worsens metabolism, whereas a mineralocorticoid receptor (MR) antagonist reduced insulin resistance in 3T3-L1 preadipocytes (6, 7) . Rondinone et al. (8) reported that 1 to 10 nM aldosterone can induce 3T3-L1 preadipocyte differentiation. Penfornis et al. (9) found that aldosterone induces T37i cells into mature brown adipocytes via an MR. What's more, research has shown that aldosterone and high-sensitivity C-reactive protein concentrations predict incident metabolic syndrome (10) . Aldosterone increases expression of IL-6 and TNF-a in mature 3T3-L1 adipocytes, and MR blockade reduces expression of IL-6 and TNF-a (11). However, the mechanism underlying this phenomenon is still not clear. Adipose tissue inflammation and fibrosis play an important role in cardiovascular disease. Human epicardial adipose tissue induces atrial myocardium fibrosis (12) . In addition, a study found that atrial fibrillation is associated with subepicardium adipose tissue remodeling in humans (13) . Whether chronic aldosterone increase in patients with PA directly affects adipose tissue inflammation and fibrosis has not yet been clarified.
In this study, we explored the fibrosis and inflammation change in perirenal and subcutaneous adipose tissue of patients with aldosterone-producing adenoma (APA). We also evaluated the effect of aldosterone in isolated human perirenal adipose tissue stromal vascular fraction (SVF) cells and investigated the effect of aldosterone in mouse 3T3-L1 and brown preadipocytes.
Methods

Patients
From October 2014 to December 2016, 31 consecutive patients who were referred to our hospital were enrolled in the study. Among them, 16 patients with APA were studied. In addition, 10 patients with normotension (NT) and 5 with EH served as controls. The diagnosis of APA and EH was based on international diagnostic guidelines (14) . The characteristics of the patients are described in Table 1 . Perirenal and subcutaneous adipose tissues were obtained from patients with APA, NT, and EH undergoing laparoscopic adrenalectomy, nephrolithotomy, or ureterolithotomy. The study was approved by the Institutional Review Board of Nanfang Hospital, and all participating individuals provided written informed consent.
Isolation of cells from the SVF of human perirenal fat
Human perirenal adipose tissue was obtained from a 52-year-old normotensive female who underwent laparoscopic ureterolithotomy. The primary SVF from human perirenal fat was isolated as described previously (15) . The primary SVF cells from human perirenal adipose tissue were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS). For adipocyte differentiation, cells were grown to 100% confluence and then differentiated with a standard brown preadipocyte differentiation protocol (16) . Twelve hours before treatment, differentiated cells were cultured in serum-free DMEM. For the aldosterone stimulation study, at the time of treatment, cells were incubated with vehicle or aldosterone (10 28 mol/L; Sigma) for 24 hours. The selected concentration of aldosterone was based on previous studies (11) .
Cell culture
Mouse 3T3-L1 preadipocytes were obtained from the type culture collection of the Chinese Academy of Sciences. The brown preadipocytes were established as previously described (17, 18) . Briefly, interscapular brown adipose tissue was isolated from new-born C57BL/6 mice and digested with collagenase, and then filtered and spun down. The pelleted SVF was plated on culture dishes, immortalized with pBabe-SV40T-puro retroviral vector (expressing large T antigen and puromycin resistant gene), and selected with puromycin. The established brown preadipocyte cell line was tested and verified for their capability of adipogenic differentiation and uncoupling protein RNA isolation/quantitative real-time polymerase chain reaction and Western blotting RNA was isolated from adipose tissue and cultured cells using Trizol (TAKARA), and complementary DNA synthesis was performed with a PrimeScript RT Reagent Kit (TAKARA). Quantitative polymerase chain reaction (PCR) was performed using a Roche LightCycler 480 Real-Time PCR System; 18S was used for normalization in human adipose tissue and SVF cells, and Arbp (38B4) was used as internal control in mouse 3T3-L1 and brown preadipocytes. Western blotting was performed as previously described (19 
Immunohistochemistry, immunofluorescence, and Masson staining
Paraffin-embedded sections of perirenal adipose tissues from patients with APA, NT, and EH were stained with Masson's trichrome as described previously (20) . TNF-a, fibronectin (FN), and collagen I (COLI) protein expression was analyzed by immunohistochemistry as described earlier (20) . Perirenal adipose tissue sections were incubated with antibodies against TNF-a (Abcam; catalog no. ab6671; RRID: AB_305641), FN (Abcam; catalog no. ab23751; RRID: AB_447656), or COLI (Abcam; catalog no. ab6308; RRID: AB_305411). For immunofluorescence, paraffin-embedded sections of perirenal adipose tissues from patients with APA, NT, and EH were incubated with antibodies against CD68 (Abcam; catalog no. ab955; RRID: AB_307338) or TNF-a (Abcam; catalog no. ab6671; RRID: AB_305641), followed by incubation with fluorophore-conjugated secondary antibodies.
Statistical analysis
Student t test was used to analyze data with a normal distribution, and the results are presented as the mean 6 standard error of the mean. Wilcoxon signed-ranks test was used for nonnormal distribution data analysis, and the results are presented as the median (25% to 75%). P , 0.05 was considered statistically significant. Table 1 describes the clinical and laboratory characteristics of the study patients. Plasma aldosterone and the aldosterone-to-renin ratio were higher and serum potassium and plasma renin activity were lower in patients with APA than in patients with EH (P , 0.05). Blood pressure and duration of hypertension were similar in both patients with APA and patients with EH. Creatinine in all patients is within normal range.
Results
Patient characteristics
Human adipose tissue
Inflammatory burden in perirenal adipose tissue of patients with APA
We investigated whether perirenal adipose tissue of patients with APA differed from that of patients with NT and EH and found that IL-6 and TNF-a messenger RNA (mRNA) levels were significantly higher in perirenal adipose tissue of patients with APA than in NT and EH patient tissues (Fig. 1A) . Western blotting confirmed increased expression of IL-6 protein in perirenal adipose tissue of patients with APA (Fig. 1B) . Immunohistochemistry analysis of perirenal adipose tissue showed that, compared with NT and EH individuals, TNF-a expression was significantly increased in patients with APA (Fig. 1D) .
Fibrotic changes in perirenal adipose tissue of patients with APA
Immunohistochemistry analysis of perirenal adipose tissue showed that FN and COLI expression was significantly higher in tissues from patients with APA than in tissues from patients with NT and EH. Masson's staining showed that perirenal adipose tissues from patients with APA developed more extensive collagen deposition compared with tissues from individuals with NT and EH (Fig. 1D) . Moreover, we detected the mRNA expression of fibrosis-related genes, including FN, COLI, early growth response factor-1 (EGR1), and transforming growth factor-b1 (TGFb1). The mRNA levels of these genes were significantly increased in perirenal adipose tissues of the APA group (Fig. 1C) .
Adipokine mRNA is upregulated in adipose tissues of patients with APA
To assess the characteristics of perirenal adipose tissue, we examined the molecular phenotype of white and brown fat. The expression of peroxisome proliferator-activated receptor g (PPARg), CCAATenhancer-binding protein (C/EBP) a, C/EBPb, UCP1, PPARg coactivator-1a (PGC1a), and cell death-inducing DFFA-like effector A (CIDEA) in perirenal adipose tissue of patients with APA were significantly increased compared with that of patients with NT and EH ( Fig. 2A and  2B ). We also found that mRNA levels of C/EBPb, PGC1a, and CIDEA in subcutaneous adipose tissues of patients with APA were dramatically increased compared with individuals with NT and EH (Fig. 2C and 2D ).
Human perirenal adipose tissue SVF cell isolation and adipocyte differentiation in vitro
To investigate the effect of aldosterone on SVF cells' characteristics and function, we isolated primary preadipocytes from human perirenal adipose tissue ( Fig. 3A  and 3B ). In addition, we treated differentiated SVF cells with aldosterone (10 nM) for 24 hours to measure mRNA expression of genes related to adipokines, inflammation, and fibrosis. Aldosterone significantly induced IL-6, FN, COLI, and TGFb1 mRNA expression in differentiated SVF cells and induced a marked upregulation of PPARg, C/EBPa, and CIDEA mRNA expression ( Fig. 3C and 3D ).
Effect of aldosterone on the expression of genes related to adipokines, inflammation, and fibrosis in cultured mouse adipocytes
To determine whether elevation of inflammation and fibrosis in perirenal adipose tissue of patients with APA were induced by high aldosterone levels, we treated 3T3-L1 and brown preadipocytes with aldosterone during differentiation. Aldosterone stimulated differentiation of 3T3-L1 and brown preadipocytes into mature adipocytes ( Fig. 4A and 4C) . Moreover, aldosterone induced an increase in adipokine gene expression in mature 3T3-L1 and brown preadipocytes, which indicated that aldosterone influences mature adipocytes (Fig. 5A and 5C ). According to the previous results, aldosterone significantly increased the expression of proinflammatory cytokines such as IL-6 and TNF-a. The mRNA levels of fibrosis genes including FN, COLI, TGFb1, and EGR1 were higher after aldosterone treatment (Fig. 4B and 4D and Fig. 5B and 5D ).
Macrophages in SVF cell and perirenal adipose tissue of patients with APA
We analyzed the mRNA expression of macrophage cell surface marker (CD68, CD11b) and CD4+ in SVF CD11b and CD4+ mRNA could barely be detected in SVF cells (cycle threshold values were ;35; data not shown). We further analyzed the previous genes' expression in perirenal adipose tissue in patients with NT, EH, and APA (Fig. 6B) . The mRNA levels of CD68, CD11b, and CD4+ were similar in perirenal adipose tissue in NT, EH, and APA. Coimmunofluorescence of CD68 and TNF-a in perirenal adipose tissues of patients with NT, EH, and APA showed that only a very small number of CD68 immunopositive cells were detected (Fig. 6C ). TNF-a immunofluorescence results showed that TNF-a protein was significantly higher in perirenal adipose tissue of patients with APA than in that of patients with NT and EH. Using immunofluorescence, we also found that these CD68+ cells coexpressed the TNF-a (Fig. 6C ).
Discussion
In this study, we demonstrated inflammation and fibrosis in perirenal adipose tissues of patients with APA, and these factors may be involved in the incidence and development of cardiovascular events observed in patients with APA. Recent data show that perirenal fat has unique properties and that its function may be different from adipose tissue in other deposits. Specifically, Svensson et al. (21) and Mohsen-Kanson et al. (22) reported that perirenal adipose tissue in healthy subjects possesses the molecular characteristics of brown adipose tissue. A recent study showed that the expression of UCP1 protein and mRNA was lower in perirenal adipose tissues from hypertensive patients compared with normotensive patients, but there was no statistical significance in subcutaneous adipose tissue (23) , which indicated that perirenal adipose tissue may have a distinct characteristic. However, available data on perirenal adipose tissue in patients with APA are limited. We observed that mRNA expression of fat-related genes such as PPARg, C/EBPa, C/EBPb, UCP1, PGC1a, and CIDEA in perirenal adipose tissue was significantly higher in the APA group than in the NT and EH groups. Recent studies have found that the prevalence rate of PA is much higher than was previously; the incidence of PA is 4.6% to 16.6% among patients with hypertension (24) . A previous study found that high-sensitivity C-reactive protein was markedly higher in patients with PA compared with matched patients with EH (25) . Another study found that the mRNA level of IL-6 and MCP-1 was similar in omental adipose tissue of patients with APA and patients with nonfunctioning adenoma (26) . A previous study demonstrated that expression of IL-6, TNF-a, and PPARg genes in visceral adipose tissues from patients with APA and patients with nonfunctioning adenoma was similar (26) . As patients with PA present a high cardiovascular disease risk compared with EH, we used patients with EH as controls to compare inflammation, and all control patients with adrenal adenoma were excluded. Moreover, we studied perirenal adipose tissue rather than visceral adipose tissue. Our results show that expression of IL-6 and TNF-a protein and mRNA in perirenal adipose tissue was significantly higher in the APA group than in the NT and EH groups, suggesting that excess aldosterone in vivo may be related to increased perirenal adipose tissue inflammation. Eplerenone (compared with placebo) reduced the risk of death and hospitalization in patients with systolic heart failure (27) , and aldosterone induced cardiac endothelial cell proliferation and perivascular fibrosis (28, 29) . Compared with EH, myocardial fibrosis is more common in patients with PA (30) . Adipose tissue fibrosis plays an important role in adipocyte dysfunction (31) . And studies have demonstrated that the extracellular matrix is associated with white adipose tissue metabolic and endocrine dysfunction (32) (33) (34) . However, there are no data available regarding perirenal adipose tissue fibrosis changes in patients with APA. Our study demonstrated that expression of genes and proteins related to fibrosis such as FN and COLI was higher in perirenal adipose tissue in patients with APA than in patients with NT and EH.
Aldosterone classically acts in a genomic manner through induction and modulation of gene transcription in target tissues expressing the cytoplasmic/nuclear MR (35) . Previous studies have demonstrated that in animal models, aldosterone-induced inflammation occurs via a genomic mechanism in which the expression and activation of NFkB are increased (36) . Moreover, multiple studies have demonstrated that administration of eplerenone reduced mRNA levels of IL-6 and TNF-a in obese https://academic.oup.com/endomice adipose tissue (36, 37) . In addition, the study also found that in diet-induced obese mice, endothelial MR activation mediates endothelial dysfunction and eplerenone alleviates obesity-induced inflammation (37). Our results reveal that excess aldosterone in patients with APA may induce perirenal adipose tissue inflammation and that inflammatory factors such as IL-6 and TNF-a may cause vascular endothelium damage. In vitro, aldosterone not only enhanced the differentiation of white and brown preadipocytes but also affected the function of mature adipocytes. In accordance with a previous study (11) , our results show that aldosterone increases expression of IL-6 and TNF-a in mature 3T3-L1 adipocytes. As mentioned before, the previous study reported that aldosterone promoted T37i cells differentiation via MR (9), but Viengchareun et al. (38) reported that MR inhibits UCP1 expression in brown adipocytes (T37i cells). The authors point out that MR both allows brown preadipocytes to enter into the differentiation program and inhibits UCP1 expression (promoting intracellular triglyceride accumulation) (38) . Furthermore, a recent study reported that MR antagonist treatment induced brown adipocyte-specific markers in primary murine preadipocytes, 3T3-L1, and human primary preadipocytes (39, 40) . In 3T3-L1 cells, aldosterone decreased apelin and adiponectin levels and increased plasminogen activator inhibitor-1 (PCI-1) expression via glucocorticoid receptor but not MR (41, 42) . Furthermore, the impact of aldosterone on human perirenal adipocytes is unknown. SVF cells isolated from human perirenal adipose tissue was used to analyze the effect of aldosterone, confirming the effect of aldosterone on human adipose cells.
Macrophage accumulation in adipose tissue plays a key role in inflammation (43, 44) . Hence, we examined macrophage cell surface marker in SVF cells and perirenal adipose tissue. The results show that CD68, one of the macrophage cell surface markers, can also be detected in SVF cells. Coimmunofluorescence revealed a high density of TNF-a but detected only a very small number of CD68 immunopositive cells (Fig. 6C) . We did find that most of these CD68 immunopositive cells coexpressed TNF-a. Because the majority of TNFa immunopositive cells did not colocalize with CD68, the current results suggest that in addition to macrophages, adipocytes play an important role in the inflammation of perirenal adipose tissue in patients with APA. It has been reported that adipose tissue macrophage accumulation was associated with obesity, which contributes to TNF-a expression (43) . They performed CD68 real-time PCR and immunohistochemical analysis on human subcutaneous adipose tissues [body mass index (BMI) ranged from 19.4 to 60.1 kg/m 2 ]; the results showed that BMI and adipocyte area were predictors for CD68-positive cells. They also found that obese subjects have more CD68+ cells compared with lean subjects. Another study also reported that epididymal adipose tissue has more macrophage infiltration in obese mice than lean mice (45). However, whether or not adipose tissue macrophage accumulation occurs in patients with APA is unknown. A previous study reported that elperenone suppressed macrophage infiltration in adipose tissue of obese mice (7). In our study, patients' BMIs are lower than 27 kg/m 2 , which may be one of the reasons that we only found very few CD68-positive cells along with inflammation burden in perirenal adipose tissue of patients with APA. As we all know, both adipocytes and macrophages can release several cytokines, such as IL-6 and TNF-a (46). Our results in 3T3-L1, brown preadipocytes, and SVF-derived adipocytes also confirmed that adipocytes could release IL-6 and TNF-a with aldosterone stimulation.
In conclusion, high aldosterone in patients with APA may induce perirenal adipose tissue dysfunction and lead to inflammation and fibrosis. Future studies will need to increase the sample size and investigate the relationship of regional adipose tissue inflammation, circulating inflammatory factors, and cardiovascular events in patients with APA.
